000 01665 a2200541 4500
005 20250517052636.0
264 0 _c20160912
008 201609s 0 0 eng d
022 _a1476-5365
024 7 _a10.1038/bmt.2015.206
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChantepie, S P
245 0 0 _aAllogeneic stem cell transplantation (allo-SCT) for de novo Ph+ AML: a study from the French Society of Bone Marrow Transplantation and Cell Therapy.
_h[electronic resource]
260 _bBone marrow transplantation
_cDec 2015
300 _a1586-8 p.
_bdigital
500 _aPublication Type: Letter; Multicenter Study
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAllografts
650 0 4 _aBone Marrow Transplantation
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aFrance
_xepidemiology
650 0 4 _aHumans
650 0 4 _aLeukemia, Myeloid, Acute
_xgenetics
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPhiladelphia Chromosome
650 0 4 _aSocieties, Medical
650 0 4 _aStem Cell Transplantation
650 0 4 _aSurvival Rate
700 1 _aMichallet, M
700 1 _aBlaise, D
700 1 _aMaury, S
700 1 _aDeconinck, E
700 1 _aTabrizi, R
700 1 _aContentin, N
700 1 _aMohty, M
700 1 _aNguyen, S
700 1 _aLioure, B
700 1 _aRaus, N
700 1 _aPeffault de Latour, R
700 1 _aYakoub-Agha, I
700 1 _aReman, O
773 0 _tBone marrow transplantation
_gvol. 50
_gno. 12
_gp. 1586-8
856 4 0 _uhttps://doi.org/10.1038/bmt.2015.206
_zAvailable from publisher's website
999 _c25258632
_d25258632